RSA announces sale of Dutch Caribbean operation
Sun Alliance Insurance Overseas and Maduro & Curiel's Bank reached an agreement to sell Royal and Sun Alliance Insurance Group's (RSA) Dutch Carribean operation to Fatum General Insurance, it was announced Thursday.
Sun Alliance Insurance Overseas and Maduro & Curiel's Bank reached an agreement to sell Royal and Sun Alliance Insurance Group's (RSA) Dutch Carribean operation to Fatum General Insurance, it was announced Thursday.
The sale of the FSTE 100 company's Antilles division is subject to regulatory approvals in Curacao, Saint Maarten, Aruba and the islands of Bonaire, Saint Eustatius and Saba.
RSA, based in London, has a market capitalisation of £4,520.93m and reported £15m gross written premiums in 2011. The insurance company also has operations in Ireland, Scandinavia, Central and Eastern Europe, Canada, Asia, the Middle East and Latin America.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Fatum General Insurance -- which runs in the Netherlands, the Caribbean and Aruba -- is purchasing the operation for an undisclosed figure.
Richard Houghton, RSA Group Chief Financial Officer, said: "While relatively small in terms of the group's capitalisation, today's announcement is further evidence of our determination to utilise our capital wisely and only focus on territories where we can achieve scale and deliver attractive returns to shareholders. In the majority of our markets we are already achieving our objectives but where we see no strategic fit or route to outperformance, we are committed to taking decisive action."
Shares were down 0.71% to 125.90p at 9:56 Thursday.
RD
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published
-
Will the Autumn Budget impact investment markets?
Keir Starmer has warned the Autumn Budget will be “painful”. Will it impact investment markets and should you tweak your portfolio before 30 October?
By Katie Williams Published